Hidradenitis suppurativa
☆ In anno 2022 Stiftung Warentest ex Germania provenit, satisfactio consumptoria cum ModelDerm paulo minus fuit quam cum consultationibus telemedicinis solutis.
Hidradenitis suppurativa (scaena) in ala. Casus valde mitis est Hidradenitis suppurativa.
References
Hidradenitis suppurativa Pellis condicio est quae inveterata est, revertitur et vitam tuam graviter afficere potest. Ex inflammatione est in folliculis capillorum, et saepe ad infectiones bacteriales. Medici solent egritudo eam considerando species ulcerum quas habes (sicut noduli, abscessus, vel tractus sinus sinus) , ubi sunt (plerumque in plica cute) , et quotiens redeant et quam diu haereant.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Curae non-biologicae et non processuales communiter soli ad morbum leni adhibentur et cum therapia et chirurgia biologica componi possunt pro moderata ad morbum gravem. Recentes studia accessiones efficaciae praebent ad usus corticosteroides directe in laesiones infusorum pro HS ups et laesiones locales locales. Praeterea evidentia est suggerere solos tetracyclinos utentes tam efficaces esse quam clindamycin cum rifampicin coniungi.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Multae curationes hidradenitis suppurativae adhibentur, in iis antibioticis, retinoidibus, antiandrogenis, medicamentis immunis omni- bus, medicamentis anti-inflammatoriis, et radiotherapy pro laesiones veterum. Summo commendatur curationes adalimumab et laser Lorem. Surgeria, vel excisio simplex vel loci excisio cum insitione cutis completa, optio potior est gravibus, causis provectis, quae bene aliis curationibus non respondent.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Causa exacta plerumque obscura est, sed concretionem geneticam et environmental factores involvere creditur. Circa tertiam partem hominum cum morbo familiaris affecta est. Aliae factores periculi includunt adips et fumigans. Conditio non causatur per tabes, pauper valetudinis curandae.
Nullum remedium notum est. Laesiones secandas ut exhaurire sinant, haud cedit in insigni utilitate. Dum antibiotici communiter usi sunt, testimonium pro eorum usu pauper est. Medicamentum immunosuppressivum etiam explorari potest. In his gravioribus morbis, laser therapia vel chirurgia, ut cutis affectata removenda sit, viable esse potest. Raro laesio cutis in cancer cutem potest evolvere.
Si casus lenis hidradenitis suppurativa comprehenduntur, aestimatio frequentiae eius ab 1-4% incolarum est. Mulieres ter magis cum ea dignosci quam viri. Impetus est proprie in iuventute iuventutis.